As reported in lung cancer cells (45), we found that forward ephrin-B signaling suppresses Akt activity in CRC cells, possibly through PP2A-mediated Akt dephosphorylation (Fig. 5, E and F, S8 and S9). This evidence concerns the gene AKT1 and lung carcinoma.